Rocket Doctor AI Inc. (AIDR:CSE; TREIF:OTC; 939:FRA) is committed to empowering both physicians and patients with access to personalized healthcare regardless of who they are, where they are, or what their lifestyle brings.
The AI platform is designed by doctors, so doctors who use it get exactly what they need.
The company's digital health platform and marketplace helps to make healthcare more accessible and efficient, especially for those in rural communities.
It evaluates patient information in real-time to ensure appropriate care pathways are determined before any consultation.
A Growth Trajectory
Rocket Doctor is already making a noticeable impact in the healthcare landscape:
The Technology
Rocket Doctor is dedicated to transforming healthcare by empowering patients, providers, and healthcare systems through advances in technology.
The approach is centered on enhancing provider capabilities, not replacing clinical decisions.
By building and integrating innovative digital tools, the company's mission is to improve healthcare experiences for patients across North America.
Is Virtual Care as Good as Seeing a Doctor in Person?
Virtual appointments with Rocket Doctor are designed to provide high-quality care that is comparable to in-person visits. The platform connects patients with board-certified healthcare providers who can diagnose, treat, and manage a wide range of health concerns. Whilst focused on primary care, the platform also supports 20 other specialties.
Virtual care offers convenience, flexibility, and ongoing access to a healthcare team, making it an excellent alternative to traditional clinic visits. However, not all "virtual care" platforms and services are alike!
Clinician-Built Platform
The platform was built by doctors, for doctors, to ensure that clinicians can focus on what matters most - providing exceptional patient care.
Smart Triage System
The smart triage system evaluates patient information in real-time to ensure appropriate care pathways are determined before any consultation.
Smart Matching Technology
Not every provider is suited to every patient, so the system utilizes robust data analysis to match each patient with the best-suited provider available, and taking on board any patient preferences.
Enhanced Delivery Tools
Providers are empowered by a suite of advanced tools, including health history summarization, "autoscribe," and a range of patient care delivery features.
Multilingual Care
Through partnership with Voyce, translation services are available in over 200 different languages to further expand care accessibility.
Remote Patient Monitoring
Utilizing advanced remote monitoring devices, Rocket Doctor can gather vital health data, enabling proactive care and informed clinical decisions.
Some Exciting Statistics for Investors
Expanding Healthcare Access in New York City
Rocket Doctor In-Network Agreement Strengthens New York Footprint
This agreement includes approximately 20,000 additional members in New York under one major insurer, extending Rocket Doctor's total in-network reach to over 15 million members nationwide.
Rocket Doctor Expanding Access To 2.4 Million Members Across New York State
Rocket Doctor is now in-network with another major New York insurer, providing eligible members across the state with in-network access to services through its digital health platform.
A US$1 million grant (Healthy Aging Program) was launched in partnership with CVS Health Foundation to connect 700+ patients to primary, urgent, and mental health care by Q2 2026.
Canada
AI Software Integration
Ahead of the Competition
Building a successful digital health practice in the U.S. is hard; competitors face a minimum of 18–24+ months to replicate the position Rocket Doctor AI is in today - technology, payer contracts, credentialing, and revenue ops…with no guarantee of success.
The Best Doctors and Growing Fast
Lead Volume for scaling physicians utilizing the platform is bringing in eight qualified leads/month across MA, Commercial, Medicaid, and 50% MoM growth as plans go live.
Shares Outstanding
Approximately 94.5 million shares outstanding as of early 2026, according to data from Simply Wall St and Seeking Alpha.
Top Shareholders
Dr. Kevin Peterson, the company's founder, holds approximately 4.767% of the company's shares.
The Daily Chart
The daily chart technical action is highly impressive.
MACD, Stochastics, and RSI are all in bull mode, and MACD is particularly interesting with an imminent buy signal that is in sync with the rising histograms.
A huge bull wedge is in play, and it targets the key round number of CA$1.00.
The Weekly Chart
On the weekly chart, a huge inverse H&S pattern is in play. The daily chart bull wedge makes up the right shoulder.
The H&S target price is about CA$1.60.
Note the massive rise in volume throughout the formation of the H&S pattern; it favours the bulls.
Stochastics (14,5,5 series) adds weight to the scenario of an imminent and very powerful run for the bulls!
Stock price at time of writing: Approx. CA$0.65
Short-Term Technical Price Target: CA$0.80
Medium-Term Technical Price Target: CA$1.00
Long-Term Technical Price Target: CA$1.60
Technical Rating: Strong Speculative Buy
Investors can download the company presentation here.
Company Website: https://www.rocketdoctor.ai/
| Want to be the first to know about interesting Technology, Biotechnology / Pharmaceuticals and Life Sciences Tools & Diagnostics investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. | Subscribe |
Important Disclosures:
- Rocket Doctor AI Inc. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$3,000 and US$6,000.
-
For this article, Rocket Doctor AI Inc. has paid Street Smart, an affiliate of Streetwise Reports, US$2,500.
- As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of Rocket Doctor AI Inc.
- Author Certification and Compensation: Stewart Thomson was retained and compensated as an independent contractor by Street Smart for writing this article. Mr. Thomson is a retired Canadian financial advisor who has passed the Canadian Securities Course as well as additional technical analysis courses that were mandated by his former employer and approved by Ontario regulatory bodies. For the past 15 years, he has been editing and writing numerous financial newsletters that have a strong focus on charts. The recommendations and opinions expressed in this content reflect the personal, independent, and objective views of the author regarding any and all of the companies discussed. No part of the compensation received by the author was, is, or will be directly or indirectly tied to the specific recommendations or views expressed.
- Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services, or securities of any company.
For additional disclosures, please click here.
